老年肿瘤学研究大数据

Q2 Medicine North Carolina Medical Journal Pub Date : 2024-01-09 DOI:10.18043/001c.91420

Emilie D. Duchesneau, Heidi D. Klepin, Amresh D. Hanchate, Meng-Yun Lin, Shirley M. Bluethmann

{"title":"老年肿瘤学研究大数据","authors":"Emilie D. Duchesneau, Heidi D. Klepin, Amresh D. Hanchate, Meng-Yun Lin, Shirley M. Bluethmann","doi":"10.18043/001c.91420","DOIUrl":null,"url":null,"abstract":"Cancer is the second leading cause of death in North Carolina and approximately half of cancers are diagnosed in older adults (≥ 65 years). Cancer clinical trials in older adults are limited and there is a lack of evidence on optimal care strategies in this population. We highlight how big data can fill in gaps in geriatric oncology research.","PeriodicalId":39574,"journal":{"name":"North Carolina Medical Journal","volume":"51 28","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Big Data for Geriatric Oncology Research\",\"authors\":\"Emilie D. Duchesneau, Heidi D. Klepin, Amresh D. Hanchate, Meng-Yun Lin, Shirley M. Bluethmann\",\"doi\":\"10.18043/001c.91420\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Cancer is the second leading cause of death in North Carolina and approximately half of cancers are diagnosed in older adults (≥ 65 years). Cancer clinical trials in older adults are limited and there is a lack of evidence on optimal care strategies in this population. We highlight how big data can fill in gaps in geriatric oncology research.\",\"PeriodicalId\":39574,\"journal\":{\"name\":\"North Carolina Medical Journal\",\"volume\":\"51 28\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-01-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"North Carolina Medical Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18043/001c.91420\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"North Carolina Medical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18043/001c.91420","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 1

摘要

癌症是北卡罗来纳州的第二大死因，约有一半的癌症是在老年人（≥ 65 岁）中确诊的。针对老年人的癌症临床试验非常有限，而且缺乏针对这一人群的最佳治疗策略的证据。我们将重点介绍大数据如何填补老年肿瘤学研究的空白。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Big Data for Geriatric Oncology Research

Cancer is the second leading cause of death in North Carolina and approximately half of cancers are diagnosed in older adults (≥ 65 years). Cancer clinical trials in older adults are limited and there is a lack of evidence on optimal care strategies in this population. We highlight how big data can fill in gaps in geriatric oncology research.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

North Carolina Medical Journal Medicine-Medicine (all)

CiteScore

1.40

自引率

0.00%

发文量

121

期刊介绍： NCMJ, the North Carolina Medical Journal, is meant to be read by everyone with an interest in improving the health of North Carolinians. We seek to make the Journal a sounding board for new ideas, new approaches, and new policies that will deliver high quality health care, support healthy choices, and maintain a healthy environment in our state.

期刊最新文献

Assessing Local Public Health Governance in North Carolina Across Organizational and Governance Configurations. Behavioral Health Trends Among Perinatal North Carolina Medicaid Beneficiaries. Creating Recovery-Ready Communities. Drug Misuse Among Pediatric Patients: Encounters in the Prehospital Field. Evolution of the Science and Perception of Harm Reduction.